Researchers are optimistic that more sophisticated AI models will improve the accuracy of predicting schizophrenia and ...

Schizophrenia and bipolar disorder are severe mental illnesses that often disrupt daily life, affecting social interactions, ...

Schizophrenia and bipolar disorder are severe mental disorders that often manifest in early adulthood. Effective treatments ...

Severe mental illnesses such as schizophrenia, bipolar disorder and major depression are 56% more common in people who have chronic kidney disease compared to those who don’t have it, according to a ...

The FDA has accepted a supplemental New Drug Application submitted by Teva (NYSE:TEVA) and Medincell (OTC:MDCLF) for Uzedy ...

UZEDY is currently approved for use every one or two months as a subcutaneous long-acting injectable (LAI) for the treatment ...

Teva Pharmaceuticals (TEVA) and Medincell (MEDCL) announced that the supplemental New Drug Application sNDA for UZEDY extended-release ...

Israel-headquartered Teva Pharmaceutical Industries’ US subsidiary and France’s and Medincell announced that the supplemental ...

In a significant development concerning mental healthcare infrastructure, the Punjab and Haryana High Court has directed the ...

Pre-existing conditions add complexity to life insurance applications, but they don't have to be a barrier to protecting your ...

The 3-year-long case focuses on a former hospital employee accused of sexually abusing five psychiatric patients.

New York, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Emerging Treatments for Social Disconnection in Psychiatric Illness” ...